Association of luminal-androgen receptor (LAR) subtype with low HER2 in triple-negative breast cancer

被引：0
|
作者：
Ji, L. Min [1 ]
Ho, B. Seung [1 ]
Lee, S. E. [1 ]
Kook, Y. [1 ]
Moon, S. [1 ]
Kim, J. [1 ]
Kim, M. J. [1 ]
Bae, S. J. [1 ]
Jeong, J. [1 ]
Ahn, S. G. [1 ]
机构：
[1] Yonsei Univ, Gangnam Severance Hosp, Dept Surg, Coll Med, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.494
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
298P
引用
收藏
页码：S303 / S303
页数：1
相关论文
共 50 条
  • [1] Luminal androgen receptor (LAR) subtype of triple-negative breast cancer: molecular, morphological, and clinical features
    Vtorushin, Sergey
    Dulesova, Anastasia
    Krakhmal, Nadezhda
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2022, 23 (08): : 617 - 624
  • [2] Characterisation of luminal and triple-negative breast cancer with HER2 Low protein expression
    Atallah, Nehal M.
    Haque, Maria
    Quinn, Cecily
    Toss, Michael S.
    Makhlouf, Shorouk
    Ibrahim, Asmaa
    Green, Andrew R.
    Alsaleem, Mansour
    Rutland, Catrin S.
    Allegrucci, Cinzia
    Mongan, Nigel P.
    Rakha, Emad
    EUROPEAN JOURNAL OF CANCER, 2023, 195
  • [3] Deguelin selectively inhibits proliferation of luminal androgen receptor (LAR) triple-negative breast cancer cells
    Robles, Andrew J.
    Cai, Shengxin
    Cichewicz, Robert H.
    Mooberry, Susan L.
    CANCER RESEARCH, 2015, 75
  • [4] Characteristics, outcomes and prognostic factors of luminal androgen receptor (LAR) triple-negative breast cancer (TNBC)
    Leon-Ferre, R. A.
    Polley, M-Y
    Liu, H.
    Kalari, K. R.
    Boughey, J. C.
    Liu, M. C.
    Cafourek, V.
    Negron, V.
    Ingle, J. N.
    Thompson, K. J.
    Tang, X.
    Barman, P.
    Carlson, E.
    Visscher, D. W.
    Carter, J. C.
    Couch, F. J.
    Goetz, M. P.
    CANCER RESEARCH, 2019, 79 (04)
  • [5] Triple-negative Breast Cancer (TNBC) and Its Luminal Androgen Receptor (LAR) Subtype: A Clinicopathologic Review of Cases in a University Hospital in Northwestern Nigeria
    Liman, A. A.
    Kabir, B.
    Abubakar, M.
    Abdullahi, S.
    Ahmed, S. A.
    Shehu, S. M.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2022, 25 (01) : 97 - 104
  • [6] Deciphering the Clinicopathological, Immunological and Molecular Profile of HER2 Low Breast Cancer within Luminal and Triple-negative Breast Cancer
    Atallah, N.
    Rakha, E.
    JOURNAL OF PATHOLOGY, 2023, 261 (SUPPL1): : S18 - S18
  • [7] Molecular and Epigenetic Biomarkers in Luminal Androgen Receptor: A Triple Negative Breast Cancer Subtype
    Judes, Gaelle
    Dagdemir, Aslihan
    Karsli-Ceppioglu, Seher
    Lebert, Andre
    Dauplat, Marie-Melanie
    Rifai, Khaldoun
    Daures, Marine
    Dubois, Lucas
    Bignon, Yves-Jean
    Penault-Llorca, Frederique
    Bernard-Gallon, Dominique
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2016, 20 (10) : 610 - 613
  • [8] Combined inhibition of CDK4/6 and AKT is effective in Rb-intact triple-negative breast cancer of the luminal androgen receptor (LAR) subtype
    Kim, Gun Min
    Lee, Kyung-min
    Sudhan, Dhivya
    Lin, Albert
    Marin, Arnaldo
    Chatterjee, Sumanta
    Ye, Dan
    Kandagatla, Vishal
    Mendiratta, Saurabh
    Hanker, Ariella
    Arteaga, Carlos
    CANCER RESEARCH, 2022, 82 (04)
  • [9] The association of androgen receptor with microRNA expression in triple-negative breast cancer
    Abu Alragheb, Bayan O.
    Abushukair, Hassan
    Al-Husseini, Maysa
    Bawadi, Randa
    Ahram, Mamoun
    CANCER RESEARCH, 2023, 83 (07)
  • [10] Digital spatial profiling of immune-related proteins in luminal androgen receptor (LAR) vs non-LAR triple-negative breast cancer (TNBC)
    Leon-Ferre, Roberto A.
    Carter, Jodi M.
    Zahrieh, David M.
    Hillman, David W.
    Chumsri, Saranya
    Ma, Yaohua
    Kachergus, Jennifer M.
    Wang, Xue
    Boughey, Judy C.
    Liu, Minetta C.
    Ingle, James N.
    Kalari, Krishna R.
    Bisneto, Jose C. Villasboas
    Couch, Fergus J.
    Thompson, E. Aubrey
    Goetz, Matthew P.
    CANCER RESEARCH, 2022, 82 (04)
12345